Telemis International has acquired Micromedica Ltd.
Begium-based Telemis International, a specialist in medical imaging solutions, has consolidated its position in Italy by acquiring Turin-based Micromedica Ltd, one of the country’s leading PACS (picture archiving and communication system) vendors. Financial details have not been disclosed.
Telemis extended its operations into Italy in 2009 with the opening of Telemis Italia SRL. The acquisition of Micromedica, in line with the company's strategy to support the growth of the PACS and MACS (multimedia archiving & communication system) markets in Europe, will significantly strengthen the sales and technical support capabilities offered to Italian customers.
Micromedica has specialized in the storage and management of radiology images since it was founded (as ERRE PI) in 1975. Since then the company has built an extensive base of customers including some of Northern Italy’s largest public hospitals. After the acquisition, Gian Paolo Robutti, Micromedica's Managing Director, takes the position of General Manager for Telemis in Italy.
Oaklins' team in Italy assisted the Italian subsidiary of Telemis throughout the negotiations.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more